Project CARE: An Integrated Treatment Adherence Program for Bipolar Disorder at the Time of Prison Release - Open Trial
NCT03825640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2026-01-28
Summary
The aim of this program of research is to develop and pilot the CARE (Community treatment Adherence at Re-Entry) program, an adjunctive intervention for incarcerated individuals with bipolar disorder (BD) transitioning from prison to the community.
The purpose of this proposed project is to establish the feasibility, acceptability, and preliminary effects of this newly developed intervention on symptom outcomes.
Conditions
Interventions
- BEHAVIORAL
-
CARE
Hybrid in-person and telephone-based adjunctive intervention for bipolar disorder across the transition from prison to the community.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
Brown University
lead OTHER
Principal Investigators
-
Lauren Weinstock, PhD · Brown University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-14
- Primary Completion
- 2020-01-15
- Completion
- 2020-01-15
Countries
- United States
Study Locations
More Related Trials
-
Customized Medication Adherence Enhancement for Treating Adults With Bipolar Disorder
NCT00763919 ·Status: COMPLETED ·Phase: NA
-
Customized Medication Adherence Enhancement for Adults With Bipolar Disorder
NCT00830310 ·Status: COMPLETED ·Phase: NA
-
Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
NCT02582905 ·Status: COMPLETED ·Phase: PHASE4
-
Adapting the Bipolar Care Model for Chronic Care Management in Community-based Health Care Sites
NCT00747201 ·Status: COMPLETED ·Phase: NA
-
Open Label Trial of Acamprosate in Bipolar Alcoholics
NCT00330486 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI
NCT03198364 ·Status: COMPLETED ·Phase: NA
-
The CAG Bipolar the CAG Bipolar RCT
NCT04229875 ·Status: UNKNOWN ·Phase: NA
-
Post-Hospital Intervention for Veterans With Comorbid Bipolar and Substance Use Disorders
NCT04127604 ·Status: COMPLETED ·Phase: NA
-
A Compassionate-focused Intervention for Older People with Bipolar Disorder
NCT06882590 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cognitive-Behavior Therapy for Young Adults With Bipolar Disorder
NCT01176825 ·Status: COMPLETED ·Phase: PHASE1
-
Real-world Lithium Intake
NCT07167563 ·Status: RECRUITING
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
NCT02604277 ·Status: RECRUITING ·Phase: NA
-
Understanding Treatment Adherence Among Individuals With Bipolar Disorder
NCT00183495 ·Status: COMPLETED
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
NCT06226025 ·Status: RECRUITING ·Phase: PHASE2
-
LiveWell: A Mobile Intervention for Bipolar Disorder
NCT03088462 ·Status: COMPLETED ·Phase: NA
-
A Brief Family-centered Care Program for Bipolar Disorder
NCT02893007 ·Status: COMPLETED ·Phase: NA
-
The Evaluation and Follow-up of Patients With Bipolar Disorder
NCT00001652 ·Status: COMPLETED
-
Improving Care for Patients With Bipolar Disorder
NCT00222755 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
NCT00332098 ·Status: COMPLETED ·Phase: PHASE3
-
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558 ·Status: COMPLETED ·Phase: NA
-
Acamprosate vs. Placebo in Bipolar Alcoholics
NCT00466661 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
NCT02893371 ·Status: TERMINATED
-
Effects of Smartphone-based Treatment for Bipolar Disorder - the Smart Bipolar
NCT04230421 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Effectiveness of Family-Focused Psychoeducation in Treating Adolescents With Bipolar Disorder
NCT00571402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
NCT01212588 ·Status: TERMINATED ·Phase: PHASE2